BALCHEM CORP 10-Q

Item 1A. Risk Factors There have been no material changes to our Risk Factors contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and Part II, Item 1A of the Company’s Form 10-Q for the quarterly period ended June 30, 2022. For further discussion of our Risk Factors, refer to the “Risk Factors” disclosures contained in our Annual Report on Form 10-K for the year ended December 31, 2021, and Part II, Item 1A of the Company’s Form 10-Q for the quarterly period ended June 30, 2022. Item 2C. Issuer Purchase of Equity Securities The following table summarizes the share repurchase activity for the nine months ended September 30, 2022: Total Number of Shares Purchased (1) Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Programs (1) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs January 1-31, 2022 88,154 $ 147.03 88,154 $ 125,951,395 February 1-28, 2022 57,531 $ 139.75 57,531 $ 111,675,367 March 1-31, 2022 100,000 $ 135.98 100,000 $ 95,065,135 First Quarter 245,685 245,685 April 1-30, 2022 245 $ 125.36 245 $ 87,609,591 May 1-31, 2022 4,550 $ 120.01 4,550 $ 83,324,693 June 1-30, 2022 181 $ 125.87 181 $ 83,370,521 Second Quarter 4,976 4,976 July 1-31, 2022 — $ — — $ 83,370,521 August 1-31, 2022 361 $ 127.77 361 $ 88,643,248 September 1-30, 2022 — $ — — $ 88,643,248 Third Quarter 361 361 Total 251,022 251,022 (1) Our Board of Directors has approved a stock repurchase program. The total authorization under this program is 3,763,038 shares. Since the inception of the program in June 1999, a total of 3,069,266 shares have been purchased. There is no expiration for this program. 39 Item 6. Exhibits Exhibit Number Description Exhibit 10.1 Theodore L. Harris Stock Option Grant Agreement, dated September 15, 2022 Exhibit 31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a). Exhibit 31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a). Exhibit 32.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code. Exhibit 32.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code. 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 40 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BALCHEM CORPORATION By: /s/ Theodore L. Harris Theodore L. Harris, Chairman, President and Chief Executive Officer By: /s/ Martin Bengtsson Martin Bengtsson, Executive Vice President and Chief Financial Officer Date: November 4, 2022 41